These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 26441037)

  • 1. The use of circulating biomarkers in early clinical trials in patients with cancer.
    D'Arcangelo M; Margetts J; Greystoke A
    Biomark Med; 2015; 9(10):1011-23. PubMed ID: 26441037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumour cells and circulating endothelial cells as biomarkers in oncology.
    Strijbos MH
    Acta Clin Belg; 2011; 66(5):332-6. PubMed ID: 22145267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Biomarkers for Prediction of Treatment Response.
    Cappelletti V; Appierto V; Tiberio P; Fina E; Callari M; Daidone MG
    J Natl Cancer Inst Monogr; 2015 May; 2015(51):60-3. PubMed ID: 26063889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
    Gingras I; Salgado R; Ignatiadis M
    Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical studies monitoring circulating and disseminated tumor cells in gastrointestinal cancers.
    Eliasova P; Kolostova K; Kobierzycki C; Bobek V
    Folia Histochem Cytobiol; 2013; 51(4):265-77. PubMed ID: 24497131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells as pharmacodynamic biomarker in early clinical oncological trials.
    Devriese LA; Voest EE; Beijnen JH; Schellens JH
    Cancer Treat Rev; 2011 Dec; 37(8):579-89. PubMed ID: 21592671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.
    Alberter B; Klein CA; Polzer B
    Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid functionalized surface highlights 5-methylcytosine-genomic content within circulating tumor cells.
    Malara N; Coluccio ML; Limongi T; Asande M; Trunzo V; Cojoc G; Raso C; Candeloro P; Perozziello G; Raimondo R; De Vitis S; Roveda L; Renne M; Prati U; Mollace V; Di Fabrizio E
    Small; 2014 Nov; 10(21):4324-31. PubMed ID: 25044603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress of Circulating Tumor Cells in Cancer Management.
    Zhang C; Wang L; Guan Y; Sun Y; Liu X; Zhu D; Guo Q
    Technol Cancer Res Treat; 2016 Jun; 15(3):509-16. PubMed ID: 25948322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging circulating biomarkers in glioblastoma: promises and challenges.
    Touat M; Duran-Peña A; Alentorn A; Lacroix L; Massard C; Idbaih A
    Expert Rev Mol Diagn; 2015; 15(10):1311-23. PubMed ID: 26394701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating biomarkers in malignant melanoma.
    Alegre E; Sammamed M; Fernández-Landázuri S; Zubiri L; González Á
    Adv Clin Chem; 2015; 69():47-89. PubMed ID: 25934359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical relevance of circulating cell-free microRNAs in cancer.
    Schwarzenbach H; Nishida N; Calin GA; Pantel K
    Nat Rev Clin Oncol; 2014 Mar; 11(3):145-56. PubMed ID: 24492836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Cancer Biomarkers.
    I H; Cho JY
    Adv Clin Chem; 2015; 72():107-70. PubMed ID: 26471082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
    Paterlini-Bréchot P
    Future Oncol; 2011 Jul; 7(7):849-71. PubMed ID: 21732757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular oncology and the neoadjuvant setting: the perfect blend for treatment personalization and clinical trial design.
    Generali D; Berruti A; Foroni C; Bazzola L; Andreis D; Allevi G; Bersiga A; Dogliotti L; Fox SB; Harris AL; Bottini A
    J Natl Cancer Inst Monogr; 2011; 2011(43):67-70. PubMed ID: 22043044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating tumour cells in metastatic head and neck cancers.
    Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
    Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Search for circulating tumor cells: Seriously, a real cancer screening tool?].
    Hofman P
    J Mal Vasc; 2015 Dec; 40(6):335-7. PubMed ID: 26526763
    [No Abstract]   [Full Text] [Related]  

  • 20. Liquid biopsy: a perspective for probing blood for cancer.
    Jeffrey SS; Toner M
    Lab Chip; 2019 Feb; 19(4):548-549. PubMed ID: 30688954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.